---
title: "200028.SZ (200028.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/200028.SZ/news.md"
symbol: "200028.SZ"
name: "200028.SZ"
parent: "https://longbridge.com/en/quote/200028.SZ.md"
datetime: "2026-03-04T23:06:19.278Z"
locales:
  - [en](https://longbridge.com/en/quote/200028.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/200028.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/200028.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/200028.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/200028.SZ/news.md)


# 200028.SZ (200028.SZ) — Related News

### [](https://longbridge.com/en/news/277368324.md)
*2026-03-01T19:34:37.000Z*
> The Turkish Financial Stability Committee stated that Turkey is prepared to take measures to mitigate the negative impac

### [Sinopharm Holdings' subsidiary Sinopharm Accord is expected to see its net profit rise by nearly 90% last year](https://longbridge.com/en/news/273627659.md)
*2026-01-25T23:57:00.000Z*
> Sinopharm Holdings' subsidiary Sinopharm Accord expects net profit to grow by 64.20% to 89.11% in 2025, reaching between

### [Sinopharm Subsidiary Sinopharm Accord Reports Q3 Revenue Decline](https://longbridge.com/en/news/263490727.md)
*2025-10-30T10:47:08.000Z*
> Sinopharm Group Co. Ltd. reported that its subsidiary, China National Accord Medicines Corporation Ltd. (Sinopharm Accor

### [Sinopharm Accord's net profit attributable to shareholders for the first three quarters was 957 million yuan, a year-on-year decrease of 10.18%](https://longbridge.com/en/news/262002608.md)
*2025-10-21T08:20:08.000Z*
> Sinopharm Accord's performance report for the first three quarters of 2025 shows an operating income of 55.124 billion y

### [Sinopharm Accord Reports Decline in Revenue and Profits for H1 2025](https://longbridge.com/en/news/255230855.md)
*2025-08-29T13:54:48.000Z*
> Sinopharm Group Co. Ltd. reported a decline in revenue and profits for its subsidiary, China National Accord Medicines C

### [Sinopharm Accord's net profit attributable to shareholders in the first half of the year was 666 million yuan, a year-on-year decrease of 10.43%](https://longbridge.com/en/news/253006484.md)
*2025-08-14T09:46:03.000Z*
> Sinopharm Accord released its semi-annual performance report for 2025, achieving operating revenue of 36.797 billion yua

### [Sinopharm Accord: The company's affiliated pharmaceutical retail stores have not yet been involved in tax refund business](https://longbridge.com/en/news/235968203.md)
*2025-04-15T03:42:22.000Z*
> On April 15th, Sinopharm Accord stated on the interactive platform that its subsidiary pharmaceutical retail stores have

### [Sinopharm Accord, a subsidiary of Sinopharm, earned 642 million RMB last year, a decline of 59.8%](https://longbridge.com/en/news/232116116.md)
*2025-03-17T15:55:31.000Z*
> Sinopharm Holdings announced that its subsidiary Sinopharm Accord's performance for the year 2024 showed a total operati

### [Four subsidiaries in bankruptcy liquidation, two deregistered, "ten-thousand-store giant" Sinopharm Accord accelerates "downsizing"](https://longbridge.com/en/news/228690953.md)
*2025-02-18T12:00:11.000Z*
> Sinopharm Accord (000028) has decided to liquidate its subsidiaries Jilin Chengda Fangyuan Pharmaceutical Chain Co., Ltd